VisitVizor
Loading your workspace
Preparing your dashboard, records, and imaging tools.
VisitVizor
Preparing your dashboard, records, and imaging tools.
Guides and updates that help you understand cancer care without the jargon.
A clear explanation of cancer biomarkers and genetic testing—what tests are done, why they’re ordered, what results mean, and how they influence modern treatment decisions.
A practical guide to bladder cancer care—why depth of invasion matters, typical treatment pathways, and how immunotherapy and targeted approaches fit in advanced disease.
A clear guide to blood cancers—what they are, how doctors classify them, and the modern treatment tools including targeted therapy, immunotherapy, CAR-T, and bispecific antibodies.
A clear guide to brain tumor care—why molecular testing matters, what typical treatment includes, and how goals and options differ across glioma subtypes.
A detailed guide to breast cancer care—HR+/HER2-, HER2+, and triple-negative—how treatment is chosen, and what’s changing with newer therapies like antibody–drug conjugates.
A patient-friendly overview of common cancer treatment types, how care teams choose plans, and what to ask your oncologist.
A practical guide to colorectal cancer care—what changes treatment decisions, how biomarkers like MSI/MMR matter, and what options are used across stages.
A clear guide to endometrial cancer care—how stage and pathology risk features guide surgery, radiation, and systemic therapy, and why molecular testing is increasingly important.
A clear, detailed guide to modern lung cancer care—subtypes, biomarkers, first-line options, and what changes when treatments stop working.
A serious, plain-language guide to ovarian cancer care—subtypes, staging, surgery plus chemotherapy, maintenance therapy concepts, and what changes options over time.
A serious, plain-language guide to pancreatic cancer care—how stage drives options, why chemotherapy is central, and which biomarkers can open additional approaches.
A clear guide to prostate cancer care—risk groups, hormone therapy (ADT), modern systemic options, radiopharmaceuticals, and what comes next if treatments stop working.
Every scan comes with a radiology report—but they’re written for clinicians, not patients. Learn what common terms mean, what they don’t mean, and how VisitVizor helps translate imaging into plain English.
A cancer-by-cancer overview of commonly tested biomarkers, what they’re used for, and when they influence treatment decisions.
A 2025 review explores a wide range of emerging cancer therapies, highlighting immune-based, gene-driven, metabolic, and protein-targeting strategies that aim to improve precision and overcome treatment resistance.